Infliximab | M | 1923 | RA | 1972 | 2 | 0 | +? | Hodgkin | 129 | Fatal |
July 2000–Nov 2000 | | | | | SSZ, ama | | | Nov 2000 | | Nov 2000 |
| | | | | | | | | | |
Infliximab Apr 2000–Dec 2002 | F | 1926 | RA, keratitis | 1978 | 2 MTX, CYC | MTX | ++ | Non-Hodgkin Maxilla | 180 | Alive |
| | | | | | | | Oct 2000 | | |
| | | | | | | | | | |
Infliximab Feb 2000–Sep 2001 | F | 1943 | RA | 1989 | 6 MTX, SSZ, gold IM and oral, ama | 0 | +++ | Non-Hodgkin, B-lcc, inguinal | 570 | Alive |
| | | | | | | | Sep 2001 | | |
| | | | | | | | | | |
Infliximab, then etanercept Mar 1999–Sep 1999, Sep 1999-Aug 2002, respectively | F | 1954 | RA | 1989 | 5 MTX, SSZ ciclosp, gold IM, penicillamine | MTX | +++ | MALT, lung Aug 2002 | 1081 | Fatal Postmortem MALT diagnosis in Aug 2002 |
| | | | | | | | | | |
Etanercept Apr 1999–Dec 1999 | F | 1918 | RA | 1994 | 3 MTX, SSZ, gold IM | 0 | +? | Immuno-cytoma, breast Dec 1999 | 220 | Fatal June 2000 |
| | | | | | | | | | |
Etanercept Apr 1999–July 2000 | M | 1925 | RA | 1976 | 1 MTX | MTX | ++ | Acute myeloic leukaemia, trisomi 8 chromosome | 440 | Moved abroad, fatal Jan 2002 |
| | | | | | | | Nov 2000 | | |